Hot Flashes Treatment – Pfizer’s Drug PRISTIQ Shown to Reduce Menopause Symptoms

by Laura Ramirez on July 8, 2011

PRISTIQ® a hot flashes treatmentᅠmanufactured by Pfizer has just undergone extensive study with impressive results. The product was shown to significantly decrease both the number and intensity of hot flashes in menopausal women. This is good news for women whose hot flashes wake them up all night and regularly disrupt their daily lives. Many mature women report that night sweats and hot flashes are the most aggravating symptoms associated with menopause.

Pfizer Inc. (NYSE: PFE) today announced results from a Phase 3 12-week efficacy sub-study, which found that PRISTIQ® (desvenlafaxine), a serotonin-norepinephrine reuptake inhibitor (SNRI), significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women…

hot flashes treatment

Hot Flashes treatment reduces frequency and intensity of symptoms

PRISTIQ was originally developed to treat depressive disorder and is FDA-approved for this use. ᅠRegarding its use as a hot flashes treatment, women in the study said their hot flashes were reduced in frequency by more than half and the intensity decreased as well.ᅠ

If you are suffering from moderate to severe hot flashes (as more than 75% of menopausal women are), it might be worth your while to discuss the use of PRISTIQ with your doctor. If you try it, do come back and share your experience about its effectiveness with other women.

>Click here to read the original post

 

Be Sociable, Share!

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: